Abstract
The conformationaUy restricted, cyclic disulfide-containing enkephalin analogue [D-Pen2,D-Pen5]enkephalin (DPDPE) was modified by halogenation (F, Cl, Br, I) of the phenylalanine-4 residue in the para position. The potency and selectivity of these analogues for the δ opioid receptor was greater than that of the parent peptide. The analogues possessed greater potency and affinity for the δ receptors than DPDPE in the mouse vas deferens assay and in radioreceptor assays (against [3H]DPDPE), respectively. [p-ClPhe4]DPDPE was the most selective in the radioligand binding assays(IC50(δ) = 574), being about 5-fold more δ opioid receptor selective than DPDPE in this assay, whereas [p-IPhe4]DPDPE was the most selective in the classical bioassay systems using the mouse vas deferens and guinea pig ileum assays (IC50GPI)/IC50MVD) = 17374), making it nearly 9-fold more selective than DPDPE in direct comparisons using the same assay conditions.
Original language | English (US) |
---|---|
Pages (from-to) | 249-253 |
Number of pages | 5 |
Journal | Journal of Medicinal Chemistry |
Volume | 33 |
Issue number | 1 |
DOIs | |
State | Published - Jan 1990 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery